As of 2025-07-01, the Relative Valuation of Sigilon Therapeutics, Inc. (SGTX) is (290.14) USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.47 USD, the upside of Sigilon Therapeutics, Inc. based on Relative Valuation is -1391.2%.
The range of the Relative Valuation is (193.18) - (373.09) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.6x - 25.3x | 19.0x |
| Forward P/E multiples | 13.1x - 27.7x | 20.4x |
| Fair Price | (193.18) - (373.09) | (290.14) |
| Upside | -959.7% - -1760.4% | -1391.2% |
| Date | P/E |